TITLE

Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey

AUTHOR(S)
Vaux, Sophie; Van Cauteren, Dieter; Guthmann, Jean-Paul; Le Strat, Yann; Vaillant, Véronique; de Valk, Henriette; Lévy-Bruhl, Daniel
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Following the emergence of the influenza A(H1N1)2009 virus, the French ministry of health decided to offer free vaccination against pandemic influenza to the entire French population. Groups of people were defined and prioritised for vaccination. Methods: We took a random sample of the population of mainland France and conducted a retrospective crosssectional telephone survey to estimate vaccination coverage against seasonal and pandemic influenza and to identify determinants of these vaccinations. Results: 10,091 people were included in the survey. Overall seasonal influenza vaccination coverage (IVC) remained stable in the population from the 2008-2009 season to the 2009-2010 season reaching 20.6% and 20.8% respectively. Overall pandemic IVC in the French population is estimated to be 11.1% (CI95%: 9.8 - 12.4). The highest pandemic IVC was observed in the 0-4 years age group. For individuals with health conditions associated with higher risk of influenza, pandemic IVC was estimated to be 12.2% (CI95%: 9.8 - 15.1). The main determinants associated with pandemic influenza vaccine uptake were: living in a household with a child < 5 years ORadj: 2.0 (CI95%: 1.3 - 3.1) or with two children < 5 years or more, ORadj: 2.7 (CI95%: 1.4 - 5.1), living in a household where the head of the family is university graduate (>2 years), ORadj: 2.5 (CI95%: 1.5 - 4.1), or has a higher professional and managerial occupation, ORadj: 3.0 (CI95%: 1.5 - 5.5) and being vaccinated against seasonal influenza, ORadj: 7.1 (CI95%: 5.1 - 10.0). Being an individual with higher risk for influenza was not a determinant for pandemic influenza vaccine uptake. These determinants are not the same as those for seasonal influenza vaccination. Conclusions: Overall A(H1N1)2009 influenza vaccine uptake remained low, particularly among individuals with higher risk for influenza and was lower than that observed for seasonal influenza. The reasons behind people's reluctance to be vaccinated need to be investigated further.
ACCESSION #
58027195

 

Related Articles

  • Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives. Hollingsworth, T. Déirdre; Klinkenberg, Don; Heesterbeek, Hans; Anderson, Roy M. // PLoS Computational Biology;Feb2011, Vol. 7 Issue 2, p1 

    Mitigation of a severe influenza pandemic can be achieved using a range of interventions to reduce transmission. Interventions can reduce the impact of an outbreak and buy time until vaccines are developed, but they may have high social and economic costs. The non-linear effect on the epidemic...

  • Strategy to Enhance Influenza Surveillance Worldwide. Ortiz, Justin R.; Sotomayor, Viviana; Uez, Osvaldo C.; Oliva, Otavio; Bettels, Deborah; McCarron, Margaret; Bresee, Joseph S.; Mounts, Anthony W. // Emerging Infectious Diseases;Aug2009, Vol. 15 Issue 8, p1271 

    The emergence of a novel strain of influenza virus A (H1N1) in April 2009 focused attention on influenza surveillance capabilities worldwide. In consultations before the 2009 outbreak of influenza subtype H1N1, the World Health Organization had concluded that the world was unprepared to respond...

  • Toward a universal influenza vaccine: from the perspective of protective efficacy. Yo Han Jang; Baik Lin Seong // Clinical & Experimental Vaccine Research;Jul2013, Vol. 2 Issue 2, p71 

    The authors comment on the efforts to develop a universal vaccine against influenza viruses. They describe the threat of pandemics caused by influenza viruses. They explain the factors that prevent the development of a universal influenza vaccine that offers protection against all subtypes. They...

  • Pandemic Flu Vaccine: Are We Doing Enough? Campbell, J. D. // Clinical Pharmacology & Therapeutics;Dec2007, Vol. 82 Issue 6, p633 

    Influenza experts have been trying for a long time to convince other scientists, the public health community, and the general population that preparations for a pandemic should be a priority. But it was not until the highly pathogenic H5N1 avian strain emerged, causing a great epizootic and...

  • WIN £100 worth of Amazon vouchers.  // GP: General Practitioner;12/14/2007, p13 

    The article presents information on questions asked in a survey related to influenza immunization program going on in Great Britain. The questions included in the survey relate to delays or shortages in the delivery of flu supplies in 2007, group of patients, who most frequently attend flu jabs,...

  • Influenza Vaccine Efficacy: Flu Shot vs Nasal Mist. Kuritzky, Louis // Internal Medicine Alert;11/15/2009, Vol. 31 Issue 21, p167 

    The article compares the advantage outcomes between flu shot and nasal mist as vaccination for influenza.

  • Achieving Millennium Development Goals 4 and 5: Do every mother and child really count? Kolčić, Ivana // Croatian Medical Journal;Apr2013, Vol. 54 Issue 2, p107 

    An introduction is presented in which the editor discusses various articles within the issue on topics including the effectiveness of Influenza vaccine, the risks factors associated with the acute lower respiratory infections (ALRI) and the nutrition intake for infants and young children.

  • Clinical trials of a nasal spray influenza vaccine. Wood, Stephanie // Redbook;Jan98, Vol. 190 Issue 3, p114 

    Reports the clinical trials being conducted on a nasal spray influenza vaccine in the United States. Percentage of children who got the flu after receiving the vaccine.

  • Health commish and I urge all to get vaccinated vs. flu. BLOOMBERG, MICHAEL R. // Filipino Reporter;11/30/2012, Vol. 40 Issue 52, p24 

    The article urges the people of New York City to get vaccinated against influenza, a highly contagious respiratory infection that is the third leading cause of death in the city.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics